相似文献
1
Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.
AAPS PharmSciTech. 2010 Sep;11(3):1243-9. doi: 10.1208/s12249-010-9496-7. Epub 2010 Aug 6.
2
Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.
AAPS PharmSciTech. 2009;10(3):1040-7. doi: 10.1208/s12249-009-9296-0. Epub 2009 Aug 18.
3
Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.
AAPS PharmSciTech. 2009;10(3):1032-9. doi: 10.1208/s12249-009-9293-3. Epub 2009 Aug 11.
4
PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Pharm Nanotechnol. 2017;5(2):119-137. doi: 10.2174/2211738505666170428152129.
5
Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
Colloids Surf B Biointerfaces. 2018 Jul 1;167:73-81. doi: 10.1016/j.colsurfb.2018.03.052. Epub 2018 Mar 31.
6
Engineering fast dissolving sodium acetate mediated crystalline solid dispersion of docetaxel.
Int J Pharm. 2018 Jul 10;545(1-2):329-341. doi: 10.1016/j.ijpharm.2018.04.045. Epub 2018 Apr 22.
7
Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic(®) F127 cubosomes.
Colloids Surf B Biointerfaces. 2016 Sep 1;145:845-853. doi: 10.1016/j.colsurfb.2016.05.091. Epub 2016 Jun 1.
8
Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin.
Eur J Pharm Biopharm. 2017 Sep;118:13-20. doi: 10.1016/j.ejpb.2016.12.008. Epub 2016 Dec 18.
9
Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.
Int J Pharm. 2018 Aug 25;547(1-2):648-655. doi: 10.1016/j.ijpharm.2018.06.037. Epub 2018 Jun 18.
10
[Preparation and characterization of oxaliplatin-loaded nanostructured lipid carriers].
Yao Xue Xue Bao. 2010 Sep;45(9):1177-82.
引用本文的文献
1
Design, synthesis of some novel coumarins and their nanoformulations into lipid-chitosan nanocapsule as unique antimicrobial agents.
Sci Rep. 2024 Dec 23;14(1):30598. doi: 10.1038/s41598-024-79861-7.
2
Cubosomal nanoformulation increase dissolution and anticancer activity of Fisetin in A549 lung cancer cells.
Ther Deliv. 2024 Apr 19;15(5):355-69. doi: 10.4155/tde-2023-0146.
3
Synthesis of eco-friendly layered double hydroxide and nanoemulsion for jasmine and peppermint oils and their larvicidal activities against Culex pipiens Linnaeus.
Sci Rep. 2024 Mar 22;14(1):6884. doi: 10.1038/s41598-024-56802-y.
4
Cubic nanoparticles as potential carriers for a natural anticancer drug: development, in vitro and in vivo characterization.
Drug Deliv Transl Res. 2023 Oct;13(10):2463-2474. doi: 10.1007/s13346-023-01325-8. Epub 2023 Apr 3.
5
Travoprost Liquid Nanocrystals: An Innovative Armamentarium for Effective Glaucoma Therapy.
Pharmaceutics. 2023 Mar 15;15(3):954. doi: 10.3390/pharmaceutics15030954.
6
Optimizing Dacarbazine Therapy: Design of a Laser-Triggered Delivery System Based on β-Cyclodextrin and Plasmonic Gold Nanoparticles.
Pharmaceutics. 2023 Jan 30;15(2):458. doi: 10.3390/pharmaceutics15020458.
7
pH-Responsive Hybrid Nanoassemblies for Cancer Treatment: Formulation Development, Optimization, and In Vitro Therapeutic Performance.
Pharmaceutics. 2023 Jan 18;15(2):326. doi: 10.3390/pharmaceutics15020326.
8
Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation.
Drug Deliv. 2023 Dec;30(1):2162162. doi: 10.1080/10717544.2022.2162162.
9
Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles.
Drug Deliv Transl Res. 2022 Jan;12(1):282-293. doi: 10.1007/s13346-021-00937-2. Epub 2021 Mar 25.
10
Potential combination topical therapy of anal fissure: development, evaluation, and clinical study†.
Drug Deliv. 2018 Nov;25(1):1672-1682. doi: 10.1080/10717544.2018.1507059.
本文引用的文献
1
Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.
AAPS PharmSciTech. 2009;10(3):1040-7. doi: 10.1208/s12249-009-9296-0. Epub 2009 Aug 18.
2
Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables.
AAPS PharmSciTech. 2009;10(3):1032-9. doi: 10.1208/s12249-009-9293-3. Epub 2009 Aug 11.
3
Downscaling drug nanosuspension production: processing aspects and physicochemical characterization.
AAPS PharmSciTech. 2009;10(1):44-53. doi: 10.1208/s12249-008-9170-5. Epub 2009 Jan 16.
4
Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.
AAPS PharmSciTech. 2009;10(1):1-6. doi: 10.1208/s12249-008-9168-z. Epub 2009 Jan 6.
5
Self-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition.
PLoS One. 2008;3(11):e3747. doi: 10.1371/journal.pone.0003747. Epub 2008 Nov 18.
6
Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field.
Langmuir. 2008 Dec 2;24(23):13306-11. doi: 10.1021/la801451v.
7
Behavior of freezable bound water in the bacterial cellulose produced by Acetobacter xylinum: an approach using thermoporosimetry.
AAPS PharmSciTech. 2008;9(2):701-7. doi: 10.1208/s12249-008-9104-2. Epub 2008 Jun 4.
8
Investigation of the solid state properties of amoxicillin trihydrate and the effect of powder pH.
AAPS PharmSciTech. 2007 Nov 9;8(4):E93. doi: 10.1208/pt0804093.
9
Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.
AAPS PharmSciTech. 2007 Nov 30;8(4):E100. doi: 10.1208/pt0804100.
10
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
Ann Oncol. 2008 Apr;19(4):801-6. doi: 10.1093/annonc/mdm565. Epub 2008 Jan 4.
Zotero 插件